In the chemotherapy resistance of lung cancer, miR-551b promotes the sensitivity of cells to apoptotic toxicity induced by chemotherapeutic agents by reducing the expression of cell catalase, inhibiting the accumulation of reactive oxygen species and the expression of MUC1 protein. Here, MUC1 is linked to lung carcinoma.